Park Ha Biological Technology Co., Ltd. BYAH
Park Ha Biological Technology Co., Ltd. (BYAH) earns a Piotroski F-score of 5/9 (mixed financial health). It does not currently pay a dividend. FY2025 revenue was $2.5M at a -965.0% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 5/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| BYAH | Park Ha Biological Technology Co., Ltd. | 5/9 | — | — | — |
| WNW | Meiwu Technology Co Ltd | 4/9 | — | — | — |
| SCL | STEPAN CO | 7/9 | 3.71 | 27 | +7% |
| CHD | CHURCH & DWIGHT CO INC /DE/ | 7/9 | 4.22 | 32 | +1.6% |
| ECL | ECOLAB INC. | 4/9 | 3.24 | 38.5 | +2.2% |
| PG | PROCTER & GAMBLE Co | 6/9 | 4.67 | 21.6 | +3.3% |
| VFS | VinFast Auto Ltd. | 4/9 | -13.01 | — | +57.9% |
About Park Ha Biological Technology Co., Ltd.
Park Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People's Republic of China. It operates in two segments, Product Sales and Franchise Service. The company offers various products, such as basic skin physical protection, exfoliation, and sebum film repair to surface microecological balance, and anti-aging under the Park Ha brand. It sells products to customers through directly operated retail stores, and franchisees. The company has a strategic partnership with Star Plus Action (HK) Limited to build an AI-powered skincare and health ecosystem and expand its healthcare reach. Park Ha Biological Technology Co., Ltd. has strategic partnership with Cloud Factory Technology Holdings Limited to build ai-driven ecosystem for the beauty industry. The company was founded in 2016 and is headquartered in Wuxi, the People's Republic of China. Park Ha Biological Technology Co., Ltd. operates as a subsidiary of Xiaoqiu Holding Ltd.
FAQ
Is BYAH financially healthy?
Park Ha Biological Technology Co., Ltd.'s Piotroski F-score is 5/9 (8–9 is excellent, 0–3 weak).
Does BYAH pay a dividend?
No, Park Ha Biological Technology Co., Ltd. does not currently pay a dividend.
How profitable is BYAH?
In FY2025, Park Ha Biological Technology Co., Ltd. had a net margin of -965.0% and a return on equity of -609.9%.
Is BYAH a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Park Ha Biological Technology Co., Ltd.: a Piotroski F-score of 5/9. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-10-31. Facts plus Stocktoria's own computed scores — not investment advice.